Sahajanand Medical raises Rs230 crore
SMT will use the funds to finance organic growth, for acquisitions, and to develop an aggressive research and development programme for further expansion of its portfolio of products
Mumbai: Sahajanand Medical Technologies (SMT), a manufacturer of cardiac stents, on Wednesday said it has raised Rs230 crore in a funding round led by Morgan Stanley Private Equity Asia.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more